FDA issues first "Medication Guide" for consumers using Lotronex

Patients who fill a prescription for Lotronex to treat a form of irritable bowel syndrome (IBS) will now receive an official “Medication Guide” from their pharmacist. The FDA developed the Guide to help patients (mostly female) understand “the rare but serious risks of Lotronex and how they can recognize those risks and take early action to prevent serious harm.” Information for health care professionals who prescribe Lotronex has also been updated.